During the CYTO Virtual 2020 flow cytometry conference, cell analysis instrumentation and solutions provider Cytek Biosciences (Fremont, CA) unveiled its cFluor reagents. Short for “Cytek Fluorochrome,” the cFluor reagents have all been validated on the company’s Aurora and Northern Lights cell analysis systems.
Cytek’s cell analysis instruments use an optical and electronics design that reveals the full spectrum of each dye, enabling the company’s scientists to not only fully characterize thousands of commercially available reagents, but also to identify and evaluate dyes and antibody conjugates that work optimally with full-spectrum analysis on its flow cytometers.
The first batch of reagents, the cFluor YG584, cFluor B548, and cFluor R710, are available for research use. Each of these reagents are capable of revealing more from a full-spectrum panel with a new option excitable by the yellow-green, blue, and red lasers, respectively. Other dyes in the cFluor family will be coming soon, with demonstrated ability to work in a pre-optimized panel.
Looking to the future, Cytek is combining customer feedback with its experience in designing high-parameter flow cytometry panels to start delivering pre-optimized panels. The need for validated panels has already been made clear, as the company’s customers had to pivot quickly to investigate immune response specifically against SARS-CoV-2, the virus that causes COVID-19.
For more information, please visit cytekbio.com.
Source: Cytek Biosciences press release via GlobeNewswire – August 3, 2020